Baltimore’s litigation against opioid companies has been wildly successful. Now comes the hard part of spending the money.

New evidence suggests that prenatal exposure to tetrahydrocannabinol (THC) could increase the risk of opioid addiction later ...

With the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug ...

“If this trial was about damages, the abatement trial is about recouping money that we will need to spend in the future to ...

A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...

"Interestingly, we found that this opioid-seeking phenotype occurs significantly more ... Professor and vice president for ...

(Tin, 11/13) Two drug companies will have to pay Baltimore City over $260 million in damages after a jury found them liable Tuesday for contributing to the city's opioid crisis, The Baltimore Banner ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

McKesson (MCK) and Cencora (COR) ordered by a jury in Baltimore to pay $266M in damages to the city for their role in causing ...

The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora of fueling an ...

Meanwhile, Illinois will receive a large opioid settlement; North Carolina makes progress in overdose rates; health advocates seek to extend insurance subsidies for young adults in Maryland; and more.